Close Menu

NEW YORK – Machine learning diagnostic firm Prevencio announced Tuesday it is collaborating with Seattle Children's Research Institute to develop a blood test for Kawasaki disease.

The institute will provide Prevencio with blood samples and the firm will use its HART AI platform to develop a blood test for the disease. Under the agreement, Prevencio will retain exclusive global rights to the test. The firm will use its laboratory partner Myriad RBM to measure proteins in the blood samples.

Additional terms of the deal were not disclosed.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Sponsored by
Thermo Fisher Scientific

As the world continues to contend with coronavirus and a surge in the infection rate, labs are required to run more samples than ever before. 


As new variants of SARS-CoV-2 circulate around the globe, there is growing concern among clinical laboratories that these variants may impact their ability to accurately detect the virus.